Literature DB >> 19491916

Carnitine status of pregnant women: effect of carnitine supplementation and correlation between iron status and plasma carnitine concentration.

U Keller1, C van der Wal, G Seliger, C Scheler, F Röpke, K Eder.   

Abstract

BACKGROUND/
OBJECTIVES: It has been shown that plasma carnitine concentrations markedly decline during gestation in women. The reason for this, however, is unknown. One objective of this study was to investigate the effect of carnitine supplementation on plasma carnitine concentrations in pregnant women. The second objective was to investigate the hypothesis that reduced plasma carnitine concentrations during gestation are caused by a reduced carnitine synthesis because of a diminished iron status. SUBJECTS/
METHODS: Healthy pregnant women (n=26) were randomly assigned in two groups receiving either a L-carnitine supplement (500 mg L-carnitine per day as L-carnitine L-tartrate) (n=13) or placebo (n=13) from the 13th week of gestation to term.
RESULTS: In the control group, there was a marked reduction of plasma carnitine concentration from the 12th week of gestation to term. This reduction was prevented by the supplementation of carnitine. In the control group, there was a positive relationship between the parameters of iron status (mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and ferritin) and plasma concentration of carnitine (P<0.05). Moreover, there were inverse correlations between the concentrations of ferritin and the carnitine precursor gamma-butyrobetaine in plasma, and between gamma-butyrobetaine and carnitine in plasma (P<0.05).
CONCLUSIONS: This study confirms that plasma carnitine concentrations decline in the course of pregnancy, an effect that can be prevented by the supplementation of carnitine. Data of this study, moreover, suggest that the decline of plasma carnitine concentration during pregnancy could be caused by a reduced rate of carnitine biosynthesis, possibly because of an inadequate iron status.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19491916     DOI: 10.1038/ejcn.2009.36

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  10 in total

1.  Serum metabolomic profiles suggest influence of sex and oral contraceptive use.

Authors:  Margherita Ruoppolo; Ilaria Campesi; Emanuela Scolamiero; Rita Pecce; Marianna Caterino; Sara Cherchi; Giuseppe Mercuro; Giancarlo Tonolo; Flavia Franconi
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

Review 2.  The neural stem cell/carnitine malnutrition hypothesis: new prospects for effective reduction of autism risk?

Authors:  Vytas A Bankaitis; Zhigang Xie
Journal:  J Biol Chem       Date:  2019-11-07       Impact factor: 5.157

3.  In HepG2 cells, coexisting carnitine deficiency masks important indicators of marginal biotin deficiency.

Authors:  Anna Bogusiewicz; Gunnar Boysen; Donald M Mock
Journal:  J Nutr       Date:  2014-11-19       Impact factor: 4.798

4.  Metabolomic Markers for Predicting Preeclampsia in the First Trimester of Pregnancy: A Retrospective Study.

Authors:  Ekaterina V Ilgisonis; Raisa Shalina; Nigyar Kasum-Zade; Kristina G Burkova; Oxana P Trifonova; Dmitry L Maslov; Anna L Kaysheva; Sergey S Markin
Journal:  Molecules       Date:  2022-04-12       Impact factor: 4.927

5.  Abnormal Newborn Screening in a Healthy Infant of a Mother with Undiagnosed Medium-Chain Acyl-CoA Dehydrogenase Deficiency.

Authors:  Lise Aksglaede; Mette Christensen; Jess H Olesen; Morten Duno; Rikke K J Olsen; Brage S Andresen; David M Hougaard; Allan M Lund
Journal:  JIMD Rep       Date:  2015-03-13

6.  Low availability of carnitine precursors as a possible reason for the diminished plasma carnitine concentrations in pregnant women.

Authors:  Robert Ringseis; Nicole Hanisch; Gregor Seliger; Klaus Eder
Journal:  BMC Pregnancy Childbirth       Date:  2010-04-25       Impact factor: 3.007

7.  Customized nutritional enhancement for pregnant women appears to lower incidence of certain common maternal and neonatal complications: an observational study.

Authors:  Leslie P Stone; P Michael Stone; Emily A Rydbom; Lucas A Stone; T Elliot Stone; Lindsey E Wilkens; Kathryn Reynolds
Journal:  Glob Adv Health Med       Date:  2014-11

8.  Maternal urinary metabolic signatures of fetal growth and associated clinical and environmental factors in the INMA study.

Authors:  Léa Maitre; Cristina M Villanueva; Matthew R Lewis; Jesús Ibarluzea; Loreto Santa-Marina; Martine Vrijheid; Jordi Sunyer; Muireann Coen; Mireille B Toledano
Journal:  BMC Med       Date:  2016-11-04       Impact factor: 8.775

9.  Increased Trimethylamine N-Oxide Is Not Associated with Oxidative Stress Markers in Healthy Aged Women.

Authors:  Robert Antoni Olek; Joanna Jolanta Samulak; Angelika Katarzyna Sawicka; Dace Hartmane; Solveiga Grinberga; Osvalds Pugovics; Wieslawa Lysiak-Szydlowska
Journal:  Oxid Med Cell Longev       Date:  2019-09-16       Impact factor: 6.543

10.  Pregnancy in GNE myopathy patients: a nationwide repository survey in Japan.

Authors:  Wakako Yoshioka; Naoyuki Miyasaka; Ryo Okubo; Reiko Shimizu; Yuji Takahashi; Yuriko Oda; Ichizo Nishino; Harumasa Nakamura; Madoka Mori-Yoshimura
Journal:  Orphanet J Rare Dis       Date:  2020-09-11       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.